Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Bioanalysis|August 27, 2014
Minimalistic sample preparation strategies for LC-MS quantification of large molecule biopharmaceuticals: a case study highlighting alpha-1 antitrypsin proteinKatherine Wright, Dawn Dufield
Methods in Molecular Biology (Clifton, N.J.)|April 1, 2025
An LC-MS/MS Multiplexed Method to Quantify 14 Sphingolipids in Human Cerebrospinal Fluid (CSF)Yadira Perez Paramo, Rathna Veeramachaneni, Emily Parkhurst, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 31, 2009
Development and validation of an LC-MS/MS method for quantification of cyclic guanosine 3',5'-monophosphate (cGMP) in clinical applications: a comparison with a EIA methodYanhua Zhang, Dawn Dufield, Jon Klover, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 10, 2010
Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and painJaime L Masferrer, Ben S Zweifel, Medora Hardy, et al.
Journal of Cardiovascular Pharmacology|January 5, 2013
Leukotrienes, but not angiotensin II, are involved in the renal effects elicited by the prolonged cyclooxygenase-2 inhibition when sodium intake is lowFrancisco Salazar, F Javier Salazar, Fara Saez, et al.
Journal of Pharmaceutical Sciences|March 25, 2018
Translational Pharmacokinetic/Pharmacodynamic Characterization and Target-Mediated Drug Disposition Modeling of an Anti-Tissue Factor Pathway Inhibitor Antibody, PF-06741086Chuenlei Parng, Pratap Singh, Debra D Pittman, et al.
Molecular Pharmacology|January 5, 2024
Development of an LC-MS/MS Method to Measure Sphingolipids in CSF from Patients with Multiple SclerosisYadira X Perez-Paramo, Dawn Dufield, Rathna Veeramachaneni, et al.
The AAPS Journal|November 14, 2014
Recommendations for validation of LC-MS/MS bioanalytical methods for protein biotherapeuticsRand Jenkins, Jeffrey X Duggan, Anne-Françoise Aubry, et al.
Bioanalysis|April 13, 2021
Recommendations for the content and management of Certificates of Analysis for reference standards from the GCC for bioanalysisJoseph Bower, Jennifer Zimmer, Stacie McCown, et al.
Bioanalysis|June 12, 2024
16<sup>th</sup> GCC Closed Forum: ICH M10 implementation; NGS, qPCR/dPCR, flow cytometry validation; tissue biomarkers; IS response; immunogenicity harmonization; bioanalytical industry statusJennifer Zimmer, Amanda Hays, Todd Lester, et al.
Pageof 2